SL
SMMT icon

Siren LLC’s Summit Therapeutics SMMT Stock Holding History

Siren LLC’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-695,000
Closed -$13.4M – 128
2025
Q1 		$13.4M Buy
+695,000
New +$13.9M 0.76% 31

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Siren LLC's SMMT Position: Q2 2025 in Review

Siren LLC sold out of Summit Therapeutics (SMMT) in Q2 2025, closing a stake of 695,000 shares — an estimated $13.4M sold.

Siren LLC first reported a position in SMMT in Q1 2025 and held it in 1 quarter. The position peaked at $13.4M in Q1 2025. 238 funds tracked by Wall St. Rank hold SMMT as of Q2 2025.

  • Siren LLC reported no remaining Summit Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Siren LLC sold 695,000 Summit Therapeutics shares in Q2 2025, an estimated $13.4M.
  • Siren LLC first reported a position in Summit Therapeutics in Q1 2025 and held it in 1 quarter.
  • Siren LLC's Summit Therapeutics position peaked at $13.4M in Q1 2025.
  • 238 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2025.

Based on Siren LLC's 13F filing for Q2 2025, filed 13 Aug 2025.